NR4A1 and type 1 diabetes mellitus: We have indications that this difference between pre- and postmenopausal women is related to hormonal difference related to tumor subtype because previously, we found that premenopausal women with breast cancer and diabetes more often develop tumors that do not express hormonal receptors (especially among women with type 1 diabetes) [24].